Join a panel of clinical trial researchers at 6pm on the 28th of April for a focused discussion on the new frontiers of psychedelic therapy, examining the latest evidence from ongoing studies, including forthcoming updates of the upcoming SWV PTSD trial in Cambridge, and exploring why recent research suggests microdosing may not be a good idea after all.
Tickets will be available shortly.